Complementary and alternative medicine for upper-respiratory-tract infection in children
- PMID: 16373463
- DOI: 10.2146/ajhp040613
Complementary and alternative medicine for upper-respiratory-tract infection in children
Abstract
Purpose: Evidence on the efficacy and safety of complementary and alternative medicine (CAM) for the prevention and treatment of upper-respiratory-tract infection (URTI) in children is reviewed.
Summary: A search of the literature to June 2005 identified six clinical trials examining the use of herbal medicines and nine trials of other CAM therapies. All articles were critically evaluated for adherence to standards of efficacy and safety research. Echinacea did not reduce the duration and severity of URTI. Andrographis paniculata or echinacea decreased nasal secretions (p < 0.01) but not URTI symptoms. A combination of echinacea, propolis, and ascorbic acid decreased the number of URTI episodes, the duration of symptoms, and the number of days of illness (p < 0.001). Echinacea was associated with a higher frequency of rash compared with placebo (p = 0.008). Neither ascorbic acid nor homeopathy was effective. The efficacy of zinc was not clear, and zinc may be associated with adverse effects in children. Osteopathic manipulation decreased episodes of acute otitis media (p = 0.04) and the need for tympanostomy tube insertion (p = 0.03) in children with recurrent acute otitis media. Stress-management therapy reduced the duration of URTI compared with relaxation therapy with guided imagery or standard care (p < 0.05).
Conclusion: Current data are generally inadequate to support CAM for the prevention or treatment of URTI in children.
Similar articles
-
Efficacy and safety of Echinacea purpurea in treating upper respiratory infections and complications of otitis media in children: Systematic review and meta-analysis.Clin Nutr ESPEN. 2025 Jun;67:702-713. doi: 10.1016/j.clnesp.2025.04.025. Epub 2025 Apr 29. Clin Nutr ESPEN. 2025. PMID: 40311928
-
Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children.Eur J Clin Pharmacol. 2019 Mar;75(3):303-311. doi: 10.1007/s00228-018-2601-7. Epub 2018 Nov 21. Eur J Clin Pharmacol. 2019. Retraction in: Eur J Clin Pharmacol. 2021 Jun;77(6):941. doi: 10.1007/s00228-021-03150-9. PMID: 30465062 Retracted.
-
Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.JAMA. 2003 Dec 3;290(21):2824-30. doi: 10.1001/jama.290.21.2824. JAMA. 2003. PMID: 14657066 Clinical Trial.
-
Efficacy of complex herbal compound of Echinacea angustifolia (Imoviral® Junior) in recurrent upper respiratory tract infections during pediatric age: preliminary results.Minerva Pediatr. 2011 Jun;63(3):177-82. Minerva Pediatr. 2011. PMID: 21654598
-
Self treatment with one of three self selected, ultramolecular homeopathic medicines for the prevention of upper respiratory tract infections in children. A double-blind randomized placebo controlled trial.Br J Clin Pharmacol. 2005 Apr;59(4):447-55. doi: 10.1111/j.1365-2125.2005.02336.x. Br J Clin Pharmacol. 2005. PMID: 15801940 Free PMC article. Clinical Trial.
Cited by
-
Otitis media and spinal manipulative therapy: a literature review.J Chiropr Med. 2012 Sep;11(3):160-9. doi: 10.1016/j.jcm.2012.05.006. J Chiropr Med. 2012. PMID: 23449823 Free PMC article.
-
Diagnostic Value of the Triple Combination of Serum Heparin-Binding Protein, Procalcitonin, and C-Reactive Protein in Children with Acute Bacterial Upper Respiratory Tract Infection.J Healthc Eng. 2022 Mar 10;2022:1877960. doi: 10.1155/2022/1877960. eCollection 2022. J Healthc Eng. 2022. Retraction in: J Healthc Eng. 2023 Oct 4;2023:9895750. doi: 10.1155/2023/9895750. PMID: 35310200 Free PMC article. Retracted.
-
Overview of Botanical Status in EU, USA, and Thailand.Evid Based Complement Alternat Med. 2013;2013:480128. doi: 10.1155/2013/480128. Epub 2013 Oct 21. Evid Based Complement Alternat Med. 2013. PMID: 24228061 Free PMC article. Review.
-
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial.Acta Biomed. 2022 May 11;93(2):e2022156. doi: 10.23750/abm.v93i2.11958. Acta Biomed. 2022. PMID: 35546018 Free PMC article. Clinical Trial.
-
Parental knowledge and practice on antibiotic use for upper respiratory tract infections in children, in Aksum town health institutions, Northern Ethiopia: a cross-sectional study.Pan Afr Med J. 2020 Apr 29;35:142. doi: 10.11604/pamj.2020.35.142.17848. eCollection 2020. Pan Afr Med J. 2020. PMID: 32655756 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical